271 related articles for article (PubMed ID: 25703212)
1. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
6. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
Chalmers C; Gaur S; Chew J; Wright T; Kumar A; Mathur S; Wan WY; Gould IM; Leanord A; Bal AM
Mycoses; 2011 Nov; 54(6):e795-800. PubMed ID: 21615542
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
10. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Lepe-Jiménez JA
J Antimicrob Chemother; 2013 Jan; 68(1):206-13. PubMed ID: 22945914
[TBL] [Abstract][Full Text] [Related]
11. Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.
van Hal SJ; Chen SC; Sorrell TC; Ellis DH; Slavin M; Marriott DM
J Antimicrob Chemother; 2014 Aug; 69(8):2210-4. PubMed ID: 24788656
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints.
Gamaletsou MN; Daikos GL; Walsh TJ; Perlin DS; Ortigosa CJ; Psaroulaki A; Pagoni M; Argyropoulou A; Nepka M; Perivolioti E; Kotsopoulou M; Perloretzou S; Marangos M; Kofteridis D; Grammatikou M; Goukos D; Petrikkos G; Sipsas NV
Int J Antimicrob Agents; 2014 Sep; 44(3):248-55. PubMed ID: 25108876
[TBL] [Abstract][Full Text] [Related]
13. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
Chen PY; Chuang YC; Wang JT; Sheng WH; Yu CJ; Chu CC; Hsueh PR; Chang SC; Chen YC
J Microbiol Immunol Infect; 2014 Apr; 47(2):95-103. PubMed ID: 23063082
[TBL] [Abstract][Full Text] [Related]
14. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
15. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance.
Fernández-Ruiz M; Puig-Asensio M; Guinea J; Almirante B; Padilla B; Almela M; Díaz-Martín A; Rodríguez-Baño J; Cuenca-Estrella M; Aguado JM; ; ;
J Infect; 2015 Sep; 71(3):385-94. PubMed ID: 26033696
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
Li Y; Du M; Chen LA; Liu Y; Liang Z
Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
[TBL] [Abstract][Full Text] [Related]
18. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
19. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; López J; Pitart C; Mensa J
J Hosp Infect; 2011 Feb; 77(2):157-61. PubMed ID: 21216030
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011.
Tsai MH; Wang SH; Hsu JF; Lin LC; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ; Huang YC
Clin Microbiol Infect; 2015 Nov; 21(11):1018.e1-8. PubMed ID: 26148466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]